135 related articles for article (PubMed ID: 8120063)
1. Retinoblastoma protein reverses DNA bending by transcription factor E2F.
Huber HE; Goodhart PJ; Huang PS
J Biol Chem; 1994 Mar; 269(9):6999-7005. PubMed ID: 8120063
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor E2F binds DNA as a heterodimer.
Huber HE; Edwards G; Goodhart PJ; Patrick DR; Huang PS; Ivey-Hoyle M; Barnett SF; Oliff A; Heimbrook DC
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3525-9. PubMed ID: 8475102
[TBL] [Abstract][Full Text] [Related]
3. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
4. E2F site activates transcription in fission yeast Schizosaccharomyces pombe and binds to a 30-kDa transcription factor.
Malhotra P; Manohar CF; Swaminathan S; Toyama R; Dhar R; Reichel R; Thimmapaya B
J Biol Chem; 1993 Sep; 268(27):20392-401. PubMed ID: 8376397
[TBL] [Abstract][Full Text] [Related]
5. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F.
van Wijnen AJ; van Gurp MF; de Ridder MC; Tufarelli C; Last TJ; Birnbaum M; Vaughan PS; Giordano A; Krek W; Neufeld EJ; Stein JL; Stein GS
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11516-21. PubMed ID: 8876167
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein.
Helin K; Harlow E; Fattaey A
Mol Cell Biol; 1993 Oct; 13(10):6501-8. PubMed ID: 8413249
[TBL] [Abstract][Full Text] [Related]
7. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon.
Thomas NS; Pizzey AR; Tiwari S; Williams CD; Yang J
J Biol Chem; 1998 Sep; 273(37):23659-67. PubMed ID: 9726970
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.
Wu EW; Clemens KE; Heck DV; Münger K
J Virol; 1993 Apr; 67(4):2402-7. PubMed ID: 8445736
[TBL] [Abstract][Full Text] [Related]
9. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
10. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
11. A role for a bent DNA structure in E2F-mediated transcription activation.
Cress WD; Nevins JR
Mol Cell Biol; 1996 May; 16(5):2119-27. PubMed ID: 8628278
[TBL] [Abstract][Full Text] [Related]
12. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
Sellers WR; Rodgers JW; Kaelin WG
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.
Peeper DS; Keblusek P; Helin K; Toebes M; van der Eb AJ; Zantema A
Oncogene; 1995 Jan; 10(1):39-48. PubMed ID: 7824278
[TBL] [Abstract][Full Text] [Related]
14. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2).
Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P
Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525
[TBL] [Abstract][Full Text] [Related]
15. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
16. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.
Sellers WR; Novitch BG; Miyake S; Heith A; Otterson GA; Kaye FJ; Lassar AB; Kaelin WG
Genes Dev; 1998 Jan; 12(1):95-106. PubMed ID: 9420334
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein.
Ross JF; Liu X; Dynlacht BD
Mol Cell; 1999 Feb; 3(2):195-205. PubMed ID: 10078202
[TBL] [Abstract][Full Text] [Related]
18. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.
Melamed D; Tiefenbrun N; Yarden A; Kimchi A
Mol Cell Biol; 1993 Sep; 13(9):5255-65. PubMed ID: 7689148
[TBL] [Abstract][Full Text] [Related]
19. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
